And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is quite modest. We hope to hang with a couple of the short people, catch up on chores, and then scoot off to the JP Morgan health care zoo taking place next week (which means Pharmalittle will arrive each morning later than usual). And what about you? You could go shopping for winter sweaters, since this a good time of year to find a bargain on such items. You could stay in and curl up with a good book. Or simply dream about a trip to someplace warm. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon …

Senator Chuck Grassley (R-Iowa), wants the Centers for Medicare and Medicaid Services to investigate whether two drugs, Dilaudid and Prilosec, were misclassified under the Medicaid Drug Rebate Program. Grassley, who pushed for an investigation into rebates paid by Mylan Pharmaceuticals for its EpiPen device, is concerned the government program may have overpaid for the medicines if these were not correctly classified.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for our biotech newsletter, The Readout

Get our guide to what's new in biotech delivered each morning.

Recommended Stories